2025-04-14T22:43:28-04:00 2024-12-31 731691547 SKCPA & CO 10260 SW GREENBURG ROAD SUITE 1000 PORTLAND OR 972235526 990 2024-01-01 850837695 SUBCUTANEOUS DRUG DEVELOPMENT & DELIVERY CONSORTIUM INC SUBC 5036190505 3855 SW 153RD DRIVE BEAVERTON OR 97003 DONNA FRENCH PRESIDENT 5036190505 2025-03-07 true true SEAN S KIM P00225909 5032931040 2025-03-07 2024 2025-03-06 01:10:19Z DONNA FRENCH 3855 SW 153RD DRIVE BEAVERTON OR 97003 721667 false X SUBCUTANEOUSCONSORTIUM.ORG X 2020 DE OUR MISSION IS TO COLLABORATIVELY ADVANCE THE MOST PRESSING ISSUES AND OPPORTUNITIES IN SUBCUTANEOUS DOSAGE AND DELIVERY IN A PRECOMPETITIVE MANNER. 4 4 0 4 0 0 760000 721667 -1944 0 760000 719723 0 0 0 0 0 769199 491843 769199 491843 -9199 227880 901226 1156608 275722 303224 625504 853384 OUR MISSION IS TO COLLABORATIVELY ADVANCE THE MOST PRESSING ISSUES AND OPPORTUNITIES IN SUBCUTANEOUS DOSAGE AND DELIVERY IN A PRECOMPETITIVE MANNER. false false PATIENT PREFERENCE & EXPERIENCE: PUBLISHED "PHARMACEUTICAL AND BIOTECH INDUSTRY PERSPECTIVES ON OPTIMIZING PATIENT EXPERIENCE AND TREATMENT ADHERENCE THROUGH SUBCUTANEOUS DRUG DELIVERY DESIGN" IN Q2, FINALIZED A PROPOSAL FOR ADDITIONAL RESEARCH WITH THE SUSTAINABILITY WORKSTREAM, AND COMPLETED A COMPETITIVE BID WITH THREE POTENTIAL VENDORS. HIGH DOSE HIGH VOLUME: PUBLISHED "TOWARDS MORE TOLERABLE SUBCUTANEOUS ADMINISTRATION: REVIEW OF CONTRIBUTING FACTORS FOR IMPROVING COMBINATION PRODUCT DESIGN," DRAFTED AN INDUSTRY-WIDE SURVEY AND ESTABLISHED A FRAMEWORK FOR A PUBLICATION ON THE HDHV INTEGRATED ROADMAP, AND FINALIZED A SURVEY AND FRAMEWORK FOR A PUBLICATION ON THE HARMONIZATION OF PAIN SCORING IN SC CLINICAL TRIALS. CLINICAL DEVELOPMENT & REGULATORY STRATEGY: PRESENTED AT THE CRS ANNUAL MEETING ON DEBUNKING MYTHS OF SC DELIVERY, EXECUTED A SURVEY REGARDING CLINICAL DEVELOPMENT AND REGULATORY STRATEGIES FOR HIGH-DOSE BIOLOGICS, AND COMPLETED WRITING OF A MANUSCRIPT BASED ON THE SURVEY RESULTS, WITH SUBMISSION EXPECTED BY THE END OF THE YEAR. false false false true false false false false false false false false false true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false true 2 0 true 0 false false false false false false false false X 4 4 false true false false true true true true true false false false true true true false false false false false X VITAL TECHNICAL MARKETING INC 5036190505 3855 SW 153RD DRIVE BEAVERTON OR 97003 X DONNA FRENCH PRESIDENT 5.00 X X 0 0 0 SACHIN MITTAL VICE PRESIDE 5.00 X X 0 0 0 DAVID KANG TREASURER 5.00 X X 0 0 0 MONICA ADAMS DIRECTOR 5.00 X 0 0 0 false false false CHARLES RIVER ASSOCIATES 129 SUMMIT AVE 200 SUMMIT NJ 07901 MANAGEMENT 521822 GERSON LEHRMAN GROUP INC 60 EAST 42ND ST 3RD FL NEW YORK NY 10165 RESEARCH 220000 2 MEMBERSHIP DUES 541700 721667 721667 721667 1944 -1944 -1944 -1944 719723 719723 X 311970 18175 1809 119589 628 1700 37972 491843 0 0 0 564090 646055 183333 337136 327220 901226 1156608 275722 3224 300000 275722 303224 X 625504 853384 625504 853384 901226 1156608 227880 X false false false false true false MEMBER DEPOSITS 300000 300000 FORM 990, PAGE 1, PART I, LINE 6 OFFICERS AND BOARD DIRECTORS FORM 990, PAGE 6, PART VI, LINE 3 THE ORGANIZATION DELEGATES THE MAJORITY OF OPERATIONS SECRETARIAT DUTIES TO THE MANAGEMENT COMPANY, VITAL TECHNICAL MARKETING, INC. INCLUDING BUT NOT LIMITED TO ADMINISTRATION OF THE MAJORITY OF MEETINGS, ASSISTANCE WITH MEMBERSHIP DUTIES AND ALL FINANCIAL DUTIES. FORM 990, PAGE 6, PART VI, LINE 6 GOVERNING BOARD MEMBERS: INDUSTRY EXPERTS IN SUBCUTANEOUS DRUG DEVELOPMENT & DELIVERY WHO GUIDE THE OVERALL DIRECTION OF THE SC CONSORTIUM THROUGH VOTING RIGHTS AND SERVING AS SUB-TEAM LEADS AND/OR PARTICIPANTS. SUB-TEAM COLLABORATORS: INDIVIDUALS WHO ARE NOT ON THE GOVERNING BOARD BUT WHO ACTIVELY CONTRIBUTE TO SUB-TEAM WORKSTREAMS. THESE COLLABORATORS MAY BELONG TO AN ORGANIZATION CONTRIBUTING TO THE GOVERNING BOARD OR BE ANOTHER STAKEHOLDER IN THE SC ECOSYSTEM AND ARE DIRECTLY INVOLVED IN DRIVING FORWARD SC CONSORTIUM WORKSTREAMS. FORM 990, PAGE 6, PART VI, LINE 7A MEMBERS ELECT MEMBERS OF THE GOVERNING BODY. FORM 990, PAGE 6, PART VI, LINE 7B YES, MAJOR DECISIONS OF THE GOVERNING BODY ARE APPROVED BY THE GOVERNING BOARD MEMBERS THROUGH A VOTING PROCESS, AS WRITTEN IN THE CONSORTIUM'S BYLAWS. FORM 990, PAGE 6, PART VI, LINE 11B NO PROCESS WAS USED BY THE ORGANIZATION TO REVIEW FORM 990. FORM 990, PAGE 6, PART VI, LINE 12C THE CONSORTIUM REGULARLY MONITORS AND ENFORCES COMPLIANCE BY REQUIRING ALL ORGANIZATIONAL REPRESENTATIVES (INCLUDING BOARD MEMBERS AND COMMITTEE MEMBERS) TO: ANNUALLY SIGN AN AFFIRMATION OF CONFLICT OF INTEREST POLICY AND DISCLOSURE FORM CONFIRMING THEIR UNDERSTANDING AND AGREEMENT TO COMPLY. DISCLOSE ANY POTENTIAL CONFLICTS, WHICH ARE REVIEWED BY THE BOARD. RECUSE THEMSELVES FROM DISCUSSIONS AND VOTES WHERE A CONFLICT EXISTS. UNDERGO PERIODIC REVIEWS TO ENSURE COMPLIANCE WITH TAX-EXEMPT REQUIREMENTS AND ETHICAL STANDARDS. FORM 990, PAGE 6, PART VI, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON WRITTEN REQUEST. FORM 990, PART IX, LINE 11G SUSTAINABILITY & PP/PE 96,589 0 0 HDHV 23,000 0 0 TOTAL 119,589 0 0